Stage III Prostate Adenocarcinoma AJCC v7

9 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Stage III Prostate Adenocarcinoma AJCC v7

Record	Firm	Date
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery (NCT03541850)	Jonsson Comprehensive Cancer Center	2019-01-29
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial (NCT03371719)	NRG Oncology	2018-06-20
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer (NCT03274687)	NRG Oncology	2017-07-28
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery (NCT03070886)	NRG Oncology	2017-04-05
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy (NCT02849990)	University of Washington	2017-03-09
Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery (NCT02830165)	Jonsson Comprehensive Cancer Center	2016-06-15
Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy (NCT02099864)	OHSU Knight Cancer Institute	2014-02-05
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer (NCT01787331)	University of California, San Francisco	2013-10-29
Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis (NCT01409200)	M.D. Anderson Cancer Center	2012-03-26

Track Stage III Prostate Adenocarcinoma AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.